中国的前列腺癌:流行病学趋势,基因组洞察力,以及优化管理的未来方向
Zhongyuan Wang1,2, Wenhao Xu1,2, Fangning Wan1,2
1Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Journal of the National Cancer Center
|October 20, 2025
概括
前列腺癌 (PCa) 在中国正在上升,患者往往被诊断为晚期. 需要量身定制的战略来改善中国男性的查,精准医学和治疗.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 遗传学 是一个遗传学.
背景情况:
- 在中国,前列腺癌 (PCa) 的发病率和死亡率正在增加.
- 与西方人口相比,中国患者的诊断阶段较晚,导致结果较差.
- 目前的PCa管理在很大程度上基于西方的数据,不考虑中国人口的具体情况.
研究的目的:
- 综合有关中国PCa流行病学,基因组学,临床表现和治疗差异的当前知识.
- 突出需要中国特有的PCa管理策略.
- 确定在中国背景下改善PCa护理的优先领域.
主要方法:
- 这是一个复习文章.
- 它综合了中国关于前列腺癌的现有文献.
- 涵盖的关键领域包括流行病学,基因组改变,临床特征和治疗差异.
主要成果:
- 在中国和西方人群之间,PCa诊断和结果存在显著差异.
- 现有的管理策略并未完全针对中国患者进行优化.
- 迫切需要针对人口的具体方法.
结论:
- 开发优化种族查协议至关重要.
- 整合精准医学和适应区域的预防计划是必不可少的.
- 增加临床试验参与和翻译研究,包括多组和生物标志物发现,对于推进中国的PCa护理至关重要.
更多相关视频
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
1.1K
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.1K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
